AQUINOX PHARMACEUTICALS INC - COM (AQXP)

CUSIP: 03842B101

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
23,409,871
Share change
+382,010
Total reported value
$386,429,000
Put/Call ratio
6%
Price per share
$16.51
Number of holders
48
Value change
+$7,870,919
Number of buys
27
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q4 2016

As of 31 Dec 2016, AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,409,871 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, Boxer Capital, LLC, BlackRock Advisors LLC, BlackRock Fund Advisors, Opaleye Management Inc., and BlackRock Institutional Trust Company, N.A.. This page lists 48 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.